Mr Luuk Heitink
Honorary (Fellow)
Department of Medical Biology (WEHI)
6 Scholarly works
0 Projects
HIGHLIGHTS
2024
Journal article
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers
DOI: 10.1038/s41556-023-01315-52023
Journal article
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells
DOI: 10.1038/s41418-023-01122-32023
Journal article
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Cell Death & Differentiation, (2023), 30, 4, (1033-1046), 10.1038/s41418-023-01122-3)
DOI: 10.1038/s41418-023-01137-w2022
Journal article
In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis
DOI: 10.1002/1878-0261.131792020
Journal article
LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis
DOI: 10.1016/j.stem.2020.06.0172018
Journal article
Persistent repair intermediates induce senescence
DOI: 10.1038/s41467-018-06308-9